Predictive factors for alirocumab dose increase in patients with hypercholesterolaemia and high cardiovascular risk: from the ODYSSEY COMBO I and II trials

Autor:	Vallejo-Vaz, AJ, Roth, EM, Hovingh, GK, Louie, MJ, Valcheva, V, Letierce, A, Ray, KK
Rok vydání:	2017
Předmět:	Science & Technology Cardiac & Cardiovascular Systems Cardiovascular System & Hematology Cardiovascular System & Cardiology Life Sciences & Biomedicine 1102 Cardiovascular Medicine And Haematology
Zdroj:	European Cardiology Society (ESC) Congress 2017
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______1032::0e5f0f71f2b30969e271e7ac033196ee http://hdl.handle.net/10044/1/66939 Zobrazit plný text záznamu